Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study

Masahiro Hatori, Daiki Tsuji, Kyoka Nagai, Rei Arafune, Takashi Yokokawa, Kazuyoshi Kawakami, Wataru Suzuki, Naoki Shibata, Naoki Sasahira, Masato Ozaka, Masakazu Yamaguchi, Tomonobu Uchino, Kunihiko Itoh

Open source

DOI: 10.1007/s10637-026-01632-0
Published: 2026-08-28
Container: Investigational New Drugs
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s10637-026-01632-0,
  title = {Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study},
  author = {Masahiro Hatori and Daiki Tsuji and Kyoka Nagai and Rei Arafune and Takashi Yokokawa and Kazuyoshi Kawakami and Wataru Suzuki and Naoki Shibata and Naoki Sasahira and Masato Ozaka and Masakazu Yamaguchi and Tomonobu Uchino and Kunihiko Itoh},
  year = {2026},
  journal = {Investigational New Drugs},
  doi = {10.1007/s10637-026-01632-0},
  url = {https://doi.org/10.1007/s10637-026-01632-0}
}

RIS

TY  - JOUR
TI  - Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study
AU  - Masahiro Hatori
AU  - Daiki Tsuji
AU  - Kyoka Nagai
AU  - Rei Arafune
AU  - Takashi Yokokawa
AU  - Kazuyoshi Kawakami
AU  - Wataru Suzuki
AU  - Naoki Shibata
AU  - Naoki Sasahira
AU  - Masato Ozaka
AU  - Masakazu Yamaguchi
AU  - Tomonobu Uchino
AU  - Kunihiko Itoh
PY  - 2026
JO  - Investigational New Drugs
DO  - 10.1007/s10637-026-01632-0
UR  - https://doi.org/10.1007/s10637-026-01632-0
ER  -

APA

Hatori, M., Tsuji, D., Nagai, K., Arafune, R., Yokokawa, T., Kawakami, K., Suzuki, W., Shibata, N., Sasahira, N., Ozaka, M., Yamaguchi, M., Uchino, T., & Itoh, K. (2026). Influence of LGALS3 polymorphisms on chemotherapy-induced peripheral neuropathy in patients with metastatic pancreatic cancer treated with gemcitabine and nab-paclitaxel: an exploratory biomarker analysis of the GENESECT study. Investigational New Drugs. https://doi.org/10.1007/s10637-026-01632-0

Source records

crossref · retrieved 2026-09-25T10:27:22.961Z